A
CRMD icon

AlphaQuest’s CorMedix CRMD Stock Holding History

AlphaQuest’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,267
Closed -$119K – 481
2025
Q4 		$119K Sell
10,267
-10,351
-50% -$114K 0.01% 1673
2025
Q3 		$240K Buy
20,618
+6,339
+44% +$76.6K 0.02% 1304
2025
Q2 		$176K Sell
14,279
-2,833
-17% -$31.3K 0.02% 1205
2025
Q1 		$105K Buy
17,112
+2,973
+21% +$30.8K 0.01% 1285
2024
Q4 		$115K Buy
+14,139
New +$141K 0.02% 1058

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AlphaQuest's CRMD Position: Q1 2026 in Review

AlphaQuest sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 10,267 shares — an estimated $119K sold.

AlphaQuest first reported a position in CRMD in Q4 2024 and held it in 5 quarters. The position peaked at $240K in Q3 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • AlphaQuest reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 10,267 CorMedix shares in Q1 2026, an estimated $119K.
  • AlphaQuest first reported a position in CorMedix in Q4 2024 and held it in 5 quarters.
  • AlphaQuest's CorMedix position peaked at $240K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.